Choice of the surgical approach for patients with stage I lung squamous cell carcinoma ≤3 cm

被引:1
|
作者
Chen, Chunji [1 ]
Wang, Yiyang [1 ]
Pan, Xufeng [1 ]
Fu, Shijie [1 ]
Shi, Yubo [2 ]
Yang, Jun [1 ]
Wang, Rui [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Thorac Surg, 241 West Huaihai Rd, Shanghai 200030, Peoples R China
[2] Yantaishan Hosp, Dept Thorac Surg, Yantai 264001, Peoples R China
基金
中国国家自然科学基金;
关键词
Stage I squamous cell carcinoma (stage I SCC); lobectomy; sublobectomy; CLINICOPATHOLOGICAL FEATURES; LIMITED RESECTION; CANCER RECURRENCE; SURVIVAL OUTCOMES; TUMOR SIZE; IMPACT; INVASION; LOBECTOMY; RISK; ADENOCARCINOMA;
D O I
10.21037/jtd.2018.11.51
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: We tried to explore the surgical procedures for stage I squamous cell carcinoma (SCC) with a size of <= 3 cm by using the Surveillance, Epidemiology, and End Results (SEER) database. Furthermore, we investigated the relationships between the chosen surgical option and the size of SCC. Methods: in total, 1,147 patient data sets were collected from 2010 to 2011 using the SEER database. Afterwards, 849 patients with a pT1-2aN0M0 SCC with a size of <= 3 cm after a lobectomy or sublobectomy procedure were identified. Kaplan-Meier curves were conducted to compare the overall survival (OS) rates and the lung cancer-specific survival (LCSS) rates between the two surgical approaches. Cox proportional hazards regressions were performed to discover the independent risk factors for both the OS and LCSS rates. Lastly, subgroup analysis was stratified by the size of the SCC and then classified by the 8th edition T category. Results: The sublobectomy procedure did not demonstrate a difference for the OS rate. Additionally, it demonstrated a worse LCSS rate when compared with a lobectomy for stage I SCC. In the subgroup analysis, a lobectomy was shown to have a better survival outcome only when the SCC was >2 and <= 3 cm. Multivariable analysis showed that a size of >2 to <= 3 cm, and an age of >60 were independently associated with poorer OS while the sublobectomy procedure and pleural invasions (PI) were related with a poorer LCSS rate. In the stratification of data for the tumor size, the cox proportional analysis still confirmed the protective effects of the lobectomy in subgroups of SCCs with sizes between >2 to <= 3 cm as well as the Tic category. Conclusions: The choice of the SCC surgery can be recommended based on the tumor size. A lobectomy procedure demonstrated a better LCSS against the sublobectomy in stage I SCC. SCC with sizes of >2 to <= 3 cm could become a pretty good indicator for lobectomy, while a sublobectomy may be an adequate substitute when the SCC size is <= 2 cm, especially for patients who cannot tolerate a lobectomy. Tic category can also suggest a lobectomy instead of sublobectomy for stage I SCC patients.
引用
收藏
页码:6771 / +
页数:15
相关论文
共 50 条
  • [21] Classification and survival prediction for early-stage lung adenocarcinoma and squamous cell carcinoma patients
    Tian, Suyan
    ONCOLOGY LETTERS, 2017, 14 (05) : 5464 - 5470
  • [22] Huriez syndrome: Association with squamous cell carcinoma and a surgical approach
    Riggio, E
    Spano, A
    Bonomi, S
    Nava, M
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2005, 116 (02) : 689 - 691
  • [23] The comparison of surgical patients with primary hepatic squamous cell carcinoma or adenosquamous carcinoma and surgical patients with hepatocellular carcinoma
    Yan, Long
    Xie, Feng
    Yang, Cheng
    Yu, Lihan
    Zheng, Tao
    Fu, Jun
    Yang, Jiamei
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2015, 13
  • [24] The comparison of surgical patients with primary hepatic squamous cell carcinoma or adenosquamous carcinoma and surgical patients with hepatocellular carcinoma
    Long Yan
    Feng Xie
    Cheng Yang
    Lihan Yu
    Tao Zheng
    Jun Fu
    Jiamei Yang
    World Journal of Surgical Oncology, 13
  • [25] RESULTS OF SURGICAL TREATMENT OF CARCINOMA OF LUNG BY STAGE AND CELL TYPE
    KEMENY, MM
    BLOCK, LR
    BRAUN, DW
    MARTINI, N
    SURGERY GYNECOLOGY & OBSTETRICS, 1978, 147 (06): : 865 - 871
  • [26] Erlotinib in patients with advanced lung squamous cell carcinoma
    Chi-Lu Chiang
    Chun-Ming Tsai
    Teh-Ying Chou
    Yuh-Min Chen
    Shinn-Liang Lai
    Jen-Fu Shih
    Chao-Hua Chiu
    Yu-Chin Lee
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 203 - 208
  • [27] Erlotinib in patients with advanced lung squamous cell carcinoma
    Chiang, Chi-Lu
    Tsai, Chun-Ming
    Chou, Teh-Ying
    Chen, Yuh-Min
    Lai, Shinn-Liang
    Shih, Jen-Fu
    Chiu, Chao-Hua
    Lee, Yu-Chin
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (01) : 203 - 208
  • [28] Local excision for patients with stage I anal canal squamous cell carcinoma can be curative
    Chakrabarti, Sakti
    Jin, Zhaohui
    Huffman, Brandon M.
    Yadav, Siddhartha
    Graham, Rondell P.
    Lam-Himlin, Dora M.
    Lightner, Amy L.
    Hallemeier, Christopher L.
    Mahipal, Amit
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2019, 10 (02) : 171 - 178
  • [29] Prediction of delayed neck metastasis in patients with stage I/II squamous cell carcinoma of the tongue
    Okamoto, M
    Nishimine, M
    Kishi, M
    Kirita, T
    Sugimura, M
    Nakamura, M
    Konishi, N
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2002, 31 (04) : 227 - 233
  • [30] Risk factors of lymph node metastasis in lung squamous cell carcinoma of 3cm or less in diameter
    Huang, Lijian
    Li, Wenshan
    Zhao, Lufeng
    Li, Baizhou
    Chai, Ying
    MEDICINE, 2017, 96 (29)